SAM
WST icon

Strategy Asset Managers’s West Pharmaceutical WST Stock Holding History

Strategy Asset Managers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,630
Closed -$645K – 290
2024
Q1 		$645K Buy
+1,630
New +$603K 0.14% 116
2022
Q2 		– Sell
-581
Closed -$239K – 255
2022
Q1 		$239K Sell
581
-1,352
-70% -$529K 0.05% 232
2021
Q4 		$907K Sell
1,933
-810
-30% -$349K 0.24% 78
2021
Q3 		$1.17M Buy
2,743
+717
+35% +$302K 0.26% 79
2021
Q2 		$728K Sell
2,026
-243
-11% -$80.3K 0.15% 114
2021
Q1 		$639K Buy
+2,269
New +$649K 0.15% 108

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strategy Asset Managers's WST Position: Q2 2024 in Review

Strategy Asset Managers sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 1,630 shares — an estimated $645K sold.

Strategy Asset Managers first reported a position in WST in Q1 2021 and held it in 6 quarters. The position peaked at $1.17M in Q3 2021. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Strategy Asset Managers reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Strategy Asset Managers sold 1,630 West Pharmaceutical shares in Q2 2024, an estimated $645K.
  • Strategy Asset Managers first reported a position in West Pharmaceutical in Q1 2021 and held it in 6 quarters.
  • Strategy Asset Managers's West Pharmaceutical position peaked at $1.17M in Q3 2021.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Strategy Asset Managers's 13F filing for Q2 2024, filed 2 Aug 2024.